151 related articles for article (PubMed ID: 28062630)
1. Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study.
Arrigo M; Truong QA; Onat D; Szymonifka J; Gayat E; Tolppanen H; Sadoune M; Demmer RT; Wong KY; Launay JM; Samuel JL; Cohen-Solal A; Januzzi JL; Singh JP; Colombo PC; Mebazaa A
Clin Chem; 2017 Jan; 63(1):386-393. PubMed ID: 28062630
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure.
Gayat E; Caillard A; Laribi S; Mueller C; Sadoune M; Seronde MF; Maisel A; Bartunek J; Vanderheyden M; Desutter J; Dendale P; Thomas G; Tavares M; Cohen-Solal A; Samuel JL; Mebazaa A
Int J Cardiol; 2015 Nov; 199():241-7. PubMed ID: 26209827
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD146 in the detection and grading of intravascular and tissue congestion in patients with acute dyspnoea: analysis of the prospective observational Lithuanian Echocardiography Study of Dyspnoea in Acute Settings (LEDA) cohort.
Juknevičienė R; Simonavičius J; Mikalauskas A; Čerlinskaitė-Bajorė K; Arrigo M; Juknevičius V; Alitoit-Marrote I; Kablučko D; Bagdonaitė L; Vitkus D; Balčiūnas M; Zuozienė G; Barysienė J; Žaliaduonytė D; Stašaitis K; Kavoliūnienė A; Mebazaa A; Čelutkienė J
BMJ Open; 2022 Sep; 12(9):e061611. PubMed ID: 36581965
[TBL] [Abstract][Full Text] [Related]
4. Plasma Levels of Soluble CD146 Reflect the Severity of Pulmonary Congestion Better Than Brain Natriuretic Peptide in Acute Coronary Syndrome.
Kubena P; Arrigo M; Parenica J; Gayat E; Sadoune M; Ganovska E; Pavlusova M; Littnerova S; Spinar J; Mebazaa A;
Ann Lab Med; 2016 Jul; 36(4):300-5. PubMed ID: 27139601
[TBL] [Abstract][Full Text] [Related]
5. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
[TBL] [Abstract][Full Text] [Related]
6. Assessment of successful percutaneous mitral commissurotomy by MRproANP and sCD146.
Badoz M; Arrigo M; Mogenet AC; Sadoune M; Meneveau N; Mebazaa A; Seronde MF
BMC Cardiovasc Disord; 2020 Apr; 20(1):157. PubMed ID: 32248819
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD146 and B-type natriuretic peptide dissect overhydration into functional components of prognostic relevance in haemodialysis patients.
Arrigo M; Von Moos S; Gerritsen K; Sadoune M; Tangvoraphonkchai K; Davenport A; Mebazaa A; Segerer S; Cippà PE
Nephrol Dial Transplant; 2018 Nov; 33(11):2035-2042. PubMed ID: 29733422
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction.
Wang D; Duan H; Feng J; Xiang J; Feng L; Liu D; Chen X; Jing L; Liu Z; Zhang D; Hao H; Yan X
Theranostics; 2020; 10(1):231-246. PubMed ID: 31903117
[TBL] [Abstract][Full Text] [Related]
9. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
10. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
11. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
13. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
14. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
15. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.
Ilie M; Long E; Hofman V; Selva E; Bonnetaud C; Boyer J; Vénissac N; Sanfiorenzo C; Ferrua B; Marquette CH; Mouroux J; Hofman P
Br J Cancer; 2014 Mar; 110(5):1236-43. PubMed ID: 24473396
[TBL] [Abstract][Full Text] [Related]
18. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
[TBL] [Abstract][Full Text] [Related]
19. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
